Prognosis and results after resection of very large (≥10 cm) hepatocellular carcinoma

被引:85
作者
Shah, Shimul A.
Wei, Alice C.
Cleary, Sean P.
Yang, Ilun
McGilvray, Ian D.
Gallinger, Steven
Grant, David R.
Greig, Paul D.
机构
[1] Univ Massachusetts, Sch Med, Univ Massachusetts Mem Med Ctr, Dept Surg,Div Organ Transplantat, Worcester, MA 01655 USA
[2] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Dept Surg,Multiorgan Transplantat Unit, Toronto, ON M5G 1L7, Canada
关键词
hepatocellular carcinoma; resection; vascular invasion; recurrence; ablation; liver transplant;
D O I
10.1007/s11605-007-0154-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction Few potentially curative treatment options exist besides resection for patients with very large (>= 10 cm) hepatocellular carcinoma ( HCC). We sought to examine the outcomes and risk factors for recurrence after resection of >= 10 cm HCC. Methods Perioperative and long-term outcomes were examined for 189 consecutive patients from 1993 to 2004 who underwent potentially curative resection of HCC >= 10 cm ( n= 24; 13%) vs. those with HCC < 10 cm ( n= 165; 87%). Disease-free survival (DFS) and overall survival ( OS) were determined by Kaplan-Meier analysis and patient, tumor, and treatment characteristics were compared using univariate and multivariate analysis. Results Median follow-up was 34 months. Tumors >= 10 cm were more likely to be symptomatic, of poorer grade, and have vascular invasion ( p < 0.05). Twelve patients (50%) underwent an extended resection of more than four hepatic segments or resection of adjacent organs for oncologic clearance (diaphragm-2, inferior vena cava (IVC)-2, median sternotomy-1). Postoperative complications were more common after resection of > 10 cm HCC (12/24, 50% vs. 35/165, 21%; p= 0.04). Median DFS was significantly shorter in patients with large HCC (>= 10 cm) group compared to patients with smaller HCC (8.4 vs. 38 months; p= 0.001), but overall survival was not different between the two groups (5-year survival 54% vs. 53%; p= 0.43). Seventeen patients (71%) with very large HCC developed recurrences ( 12 intrahepatic, five systemic); eight of these patients (47%) underwent additional therapy (resection-4, TACE-3, RFA-1). Pathological positive margins and vascular invasion were significant determinants of DFS in tumors >= 10 cm ( p < 0.05), but only vascular invasion was an independent risk factor for recurrence after multivariate analysis ( HR 0.17; 95% CI: 0.04 - 0.8). Median OS after recurrence was 24 months. Conclusion Surgical resection is the optimal therapy for very large (>= 10 cm) HCC. Although recurrences are common after resection of these tumors, overall survival was not significantly different from patients after resection of smaller HCC in this series.
引用
收藏
页码:589 / 595
页数:7
相关论文
共 38 条
[1]   Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study [J].
Amin, Janaki ;
Dore, Gregory J. ;
O'Connell, Dianne L. ;
Bartlett, Mark ;
Tracey, Elizabeth ;
Kaldor, John M. ;
Law, Matthew G. .
JOURNAL OF HEPATOLOGY, 2006, 45 (02) :197-203
[2]   Safety and efficacy of preoperative portal vein embolization with polyvinyl alcohol in 58 patients with liver metastases [J].
Covey, AM ;
Tuorto, S ;
Brody, LA ;
Sofocleous, CT ;
Schubert, J ;
von Tengg-Kobligk, H ;
Getrajdman, G ;
Schwartz, LH ;
Fong, Y ;
Brown, KT .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 185 (06) :1620-1626
[3]   Hepatic resection in the United States - Indications, outcomes, and hospital procedural volumes from a nationally representative database [J].
Dimick, JB ;
Cowan, JA ;
Knol, JA ;
Upchurch, GR .
ARCHIVES OF SURGERY, 2003, 138 (02) :185-191
[4]   Rising incidence of hepatocellular carcinoma in the United States [J].
El-Serag, HB ;
Mason, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750
[5]   CASH (chemotherapy-associated steatohepatitis) costs [J].
Fong, YM ;
Bentrem, DJ .
ANNALS OF SURGERY, 2006, 243 (01) :8-9
[6]   An analysis of 412 cases of hepatocellular carcinoma at a western center [J].
Fong, YM ;
Sun, RL ;
Jarnagin, W ;
Blumgart, LH .
ANNALS OF SURGERY, 1999, 229 (06) :790-799
[7]   Adult living donor liver transplantation for patients with hepatocellular carcinoma -: Extending UNOS priority criteria [J].
Gondolesi, GE ;
Roayaie, S ;
Muñoz, L ;
Kim-Schluger, L ;
Schiano, T ;
Fishbein, TM ;
Emre, S ;
Miller, CM ;
Schwartz, ME .
ANNALS OF SURGERY, 2004, 239 (02) :142-149
[8]   Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? [J].
Harada, T ;
Matsuo, K ;
Inoue, T ;
Tamesue, S ;
Inoue, T ;
Nakamura, H .
ANNALS OF SURGERY, 1996, 224 (01) :4-9
[9]  
Hemming AW, 2001, J GASTROINTEST SURG, V5, P316
[10]   Resection of hepatocellular carcinoma without preoperative tumor biopsy [J].
Levy, I ;
Greig, PD ;
Gallinger, S ;
Langer, B ;
Sherman, M .
ANNALS OF SURGERY, 2001, 234 (02) :206-209